Canary Wharf

ICH guideline S2 (R1) on genotoxicity testing and data interpretation for pharmaceuticals intended for human

Canary Wharf, E London · 2013 · 189 citations

Predictive Toxicology, Medicine, Toxicology +8

Reflection paper on risk based quality management in clinical trials

Canary Wharf, Edythe D. London · 2013 · 76 citations

Reflection Paper, Health Policy, Clinical Trial Management +9

Reflection paper on classification of advanced therapy medicinal products

Canary Wharf, Edythe D. London · 2012 · 50 citations

Reflection Paper, Active Ingredient, Medicine +5

The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

Canary Wharf, E London · 2012 · 42 citations

Drug Safety, Medicine, Patient Safety +7

Qualification Opinion of MCP-Mod as an efficient statistical methodology for model-based design and analysis of Phase II dose finding studies under model uncertainty

Canary Wharf, E London · 2014 · 37 citations

Efficient Statistical Methodology, Engineering, Phase Ii +13